vimarsana.com
Home
Live Updates
Recursion is Granted EU Orphan Drug Designation for REC-4881
Recursion is Granted EU Orphan Drug Designation for REC-4881
Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related Keywords
Germany ,
Salt Lake City ,
Utah ,
United States ,
United Kingdom ,
Italy ,
Toronto ,
Ontario ,
Canada ,
France ,
Spain ,
Meredith Brown Tuttle ,
Exchange Commission ,
Linkedin ,
Regulatory Affairs ,
Twitter ,
European Union ,
European Commission ,
Drug Administration ,
Recursion Orphan Drug Designation ,
Vice President ,
Orphan Drug Designation ,
Orphan Drug ,
Fast Track ,
Recursion Operating System ,
Recursion Data ,
Recursion Map ,
San Francisco Bay ,
Securities Litigation Reform Act ,
Technology ,
Science ,
Health ,
Biology ,
Tumors ,
Europe ,
Business ,
Pr Newswire ,